KMT2A and leukemia: The present study provides additional information underlying the pathogenic role of DNMT3A-MT with KMT2A-PTD in proliferating advantage with stem cell signature, enhanced self-renewal activity and aberrant HOXB expression in human leukemia, which may help to better understand the disease and to design better therapy for AML patients with these mutations.